Cardiovascular effects of intravenous administration of clonidine in conscious cats

Brain Research

Volumn 810, Issue 1-2, 1998, Pages 153-160

  Ally, Ahmmed ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEW ENGLAND   (United States)

Author keywords

Adrenoceptor; 5 HT(1A) receptor; Arterial blood pressure; H2 histamine receptor; Heart rate; Imidazoline receptor; Intracerebroventricular

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; CLONIDINE; SEROTONIN 1A RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE REGULATION; BRAIN LEVEL; CARDIOVASCULAR RESPONSE; CAT; DRUG EFFECT; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; BLOOD PRESSURE; CATS; CIMETIDINE; CLONIDINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEART RATE; HEMODYNAMIC PROCESSES; HISTAMINE H2 ANTAGONISTS; INJECTIONS, INTRAVENOUS; INJECTIONS, INTRAVENTRICULAR; YOHIMBINE;

EID: 0032501230     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00917-2     Document Type: Article

References (32)

1. Ally A., Hand G.A., Mitchell J.H. Cardiovascular responses to static exercise in conscious cats: effects of intracerebroventricular injection of clonidine. J. Physiol. (Lond.). 491:1996;519-527.
2. Ally A. Cardiovascular effects of central administration of clonidine in conscious cats. Brain Res. 761:1997;283-289.
3. Arthur J.M., Casanas S.J., Raymond J.R. Partial agonist properties of rauwolscine and yohimbine for the inhibition of adenyl cyclase by recombinant human 5-HT1A receptors. Biochem. Pharmacol. 45:1993;2337-2341.
4. 2-adrenoceptor involvement in the central cardiovascular action of clonidine in the conscious renal hypertensive cat. Eur. J. Pharmacol. 82:1982;155-160.
5. A.L. Berman, E.G. Jones, The Thalamus and Basal Telencephalon of the Cat, Univ. of Wisconsin Press, Madison, WI, 1982.
6. Bousquet P., Feldman J., Schwartz J. Central cardiovascular effects of alpha-adrenergic drugs: differences between catecholamines and imidazolines. J. Pharmacol. Exp. Ther. 230:1984;232-236.
7. 2-adrenergic receptors. Int. Rev. Neurobiol. 24:1983;343-431.
8. Byrum C.E., Stornetta R., Guyenet P.G. Electrophysiological properties of spinally-projecting A5 noradrenergic neurons. Brain Res. 303:1984;15-29.
9. Ciriello J., Caverson M.M., Polosa C. Function of the ventrolateral medulla in the control of the circulation. Brain Res. Rev. 396:1986;359-391.
10. Correa F.M.A., Magro I.A.S., Peres-Polon V.L. CNS mediation of cardiovascular responses to the intracerebroventricular administration of catecholamines. Trends Pharmacol. Sci. 3:1982;330-332.
11. 2-adrenoceptors in the ventrolateral medulla. Eur. J. Pharmacol. 134:1987;1-13.
12. Ernsberger P., Giuliano R., Willette R.N., Reis D.J. Role of imidazole receptors in the vasodepressor response to clonidine analogs in the rostral ventrolateral medulla. J. Pharmacol. Exp. Ther. 253:1990;408-418.
13. Finch L. The cardiovascular effects of intraventricular clonidine and BAY 1470 in conscious hypertensive cats. Br. J. Pharmacol. 52:1974;333-338.
14. Finch L., Hicks P.E. No evidence for central histamine-receptor involvement with the hypotensive effect of clonidine in cats. Eur. J. Pharmacol. 40:1976;365-368.
15. P.G. Guyenet, K.R. Lynch, A.M. Allen, D.L. Rosin, R.L. Stornetta, α2-adrenergic receptors rather than 'Imidazoline' binding sites mediate the sympatholytic effect of clonidine in the rostral ventrolateral medulla: a new look at the evidence, in: O. Trouth, R. Millis, H. Kiwull-Schone, M. Schlafke (Eds.), Ventral Brainstem Mechanisms and Control, Marcel Dekker, New York, 1993.
16. Head G.A., Korner P.I., Lewis S.L., Badoer E. Contribution of nor-adrenergic and serotonergic neurons to the circulatory effects of centrally acting clonidine and α-methyldopa in rabbits. J. Cardiovasc. Pharmacol. 5:1983;945-953.
17. Head G.A., Burke S. Importance of central noradrenergic and serotonergic pathways in the cardiovascular actions of rilmenidine and clonidine. J. Cardiovasc. Pharmacol. 18:1991;819-826.
18. 2-adrenoceptors, in: D.J. Reis, P. Bousquet, A. Parini (Eds.), The Imidazoline Receptor: Pharmacology, Functions, Ligands, and Relevance to Biology and Medicine, Ann. New York Acad. Sci., 763 (1995) 8-21.
19. Issac L. Clonidine in the central nervous system: site and mechanism of hypotensive response. J. Cardiovasc. Pharmacol. 2:1990;S5-S19.
20. Japundzic-Zigon N., Samardzic R., Beleslin D.B. Clonidine-induced emesis: a multitransmitter pathway concept. Pharmacol. Res. 35:1997;287-297.
21. 2-receptors in the hypotensive effect of clonidine. Nature. 259:1976;587-588.
22. Karppanen H. Interrelationships between clonidine and histaminergic mechanisms. Trends Pharmacol. Sci. 2:1981;35-37.
23. W. Kobinger, Central cardiovascular actions of clonidine, in: D.S. Davies, J.L. Reid (Eds.), Central action of Drugs in Blood Pressure Regulation, University Park Press, Baltimore (1975) 181-193.
24. Kobinger W. Central α-adrenergic systems as targets for hypotensive drugs. Rev. Physiol. Biochem. Pharmacol. 81:1978;39-100.
25. Li G., Regunathan S., Barrow C.J., Eshraghi J., Cooper R., Reis D.J. Agmatine: an endogenous clonidine-displacing substance in the brain. Science. 262:1994;966-969.
26. Marwaha J., Aghajanian G.K. Relative potencies of alpha-1 and alpha-2 antagonists in the locus coeruleus, dorsal raphe and dorsal lateral geniculate nuclei: an electrophysiological study. J. Pharmacol. Exp. Ther. 222:1982;287-293.
27. Merlis J.K. The effects of changes in the calcium content of the cerebrospinal fluid on spinal reflex activity in the dog. Am. J. Physiol. 131:1940;67-72.
28. Philippu A., Demmler R., Rosenberg G. Effects of centrally applied drugs on the pressor responses to hypothalamic stimulation. Naunyn-Schmiedeberg's Arch. Pharmacol. 282:1974;389-400.
29. Punnen S., Urbanski R., Krieger A.J., Sapru H.N. Ventrolateral medullary pressor area: site of hypotensive action of clonidine. Brain Res. 422:1987;36-46.
30. Sun M.K., Guyenet P.G. Effect of clonidine and gamma-aminobutyric acid on the discharges of medullo-spinal sympathoexcitatory neurons in the rat. Brain Res. 368:1986;1-17.
31. Timmermans P.B.M.W.M., Schoop A., Kwa H., VanZwieten P.A. Characterization of α-adrenergic receptors participating in the central hypotensive and sedative effects of clonidine using yohimbine, rauwolscine and corynanthine. Eur. J. Pharmacol. 70:1981;7-15.
32. Winter J.C., Rabin R.A. Yohimbine as a serotonergic agent: evidence from receptor binding and drug discrimination. J. Pharmacol. Exp. Ther. 263:1992;682-689.